Some of what RFK Jr. says about obesity prevention isn't new. But after having coined the catchy MAHA acronym, it’s likely ...

Vipin Garg, Altimmune CEO, joins 'Fast Money' to discuss Altimmune announcing topline results from its obesity drug trial, ...

It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...

The strongest influence of cardiovascular risk and obesity on reduced brain volume is seen between 55 and 64 years o ...

Results from the head-to-head study showed treatment with Zepbound resulted in 47% greater relative weight loss than Wegovy, ...

The trial enrolled 751 adults with obesity or overweight conditions and at least one weight-related medical problem ...

Spritzing on your perfume may make you feel good in the short term, but doctors are warning that a hidden ingredient in your ...

Antag Therapeutics thinks its glucose dependent insulinotropic polypeptide receptor (GIPR) antagonist could carve out a space ...

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

Obesity and visceral fat are associated with measures of amyloid burden in the brain among cognitively normal midlif ...

The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

Congress has been considering bipartisan solutions to help address the growing obesity problem for over a decade now.